ISSN:
1422-0067
Content:
The kidneys play a vital role in the basic physiological functions of the body. Kidney dysfunction impairs these physiological functions and can lead to a wide range of diseases. Damage to the kidney cells can be caused by a variety of ischemic, toxic or immunological complaints that lead to inflammation and cell death, which can lead to organ damage and, ultimately, complete failure. Although the mechanisms underlying acute kidney injury (AKI) and chronic kidney disease (CKD) are quite distinct, clinical evidence suggests that the two conditions are inextricably interconnected [1]. AKI and CKD, regardless of the underlying cause, have inflammation and activation of the immune system as the common underlying mechanisms. Inflammation, a process aimed, in principle, at detecting and fighting harmful pathogens, is, therefore, a major pathogenic mechanism for both AKI and CKD [1]. While the kidney has the remarkable ability to regenerate after an acute injury and can recover completely, depending on the type of kidney lesion, the options for clinical interventions are currently limited to fluid management and extracorporeal kidney support. However, persistent chronic inflammation can trigger renal fibrosis and chronic kidney disease. The investigation of the molecular mechanisms involved in each individual injury is currently insufficiently understood.
In:
International journal of molecular sciences, Basel : Molecular Diversity Preservation International, 2000-, Band 22, Heft 11 (2021), Seite 1-3, Artikel-ID: 5589, 1422-0067
In:
volume:22
In:
year:2021
In:
number:11
In:
pages:1-3
In:
extent:3
In:
elocationid:5589
Language:
English
DOI:
10.3390/ijms22115589
URN:
urn:nbn:de:hebis:30:3-624898
Bookmarklink